Anthem Blue Cross Blue Shield PPO
Dr. Miles Fine, DO
Otolaryngology-Head and Neck Surgery*
Age 64
Be the first to review this provider!
Dr. Miles Fine, DO
Be the first to review this provider!
Las Vegas, NV
Accepting new patients
38 years of experience
Clinical Overview
Dr. Miles Fine, DO works in Las Vegas, NV as
Dr. Fine graduated from NEW YORK INSTITUTE OF TECHNOLOGY / OLD WESTBURY in 1988. Dr. Fine is accepting new patients.
COMPARE OTHER TOP Ear, Nose, and Throat (ENT) Doctors
Contrast Dr. Fine with other nearby specialists practicing at Sunrise Hospital and Medical Center.
Make an appointment at Sunrise Hospital and Medical Center today at 702-720-3204.
Make an appointment at Sunrise Hospital and Medical Center today at 702-720-3204.
These providers are on the medical staff of Sunrise Hospital and Medical Center.
Advertisement
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
Blue Card PPO
-
Silver-NV PPOGold Choice (Employer)-NV PPOSilver Choice (Employer)-NV PPOBalanced Choice-NV PPOLumenos plans-NVNevada HMOGold Nevada PPOBoyd Gaming Network-NVBronze Choice (Employer)-NV PPONational (BlueCard) PPONational (BlueCard Basic) PPOChoice-NV PPOChoice (Tier 1 Pathway - Tier 2)-NV PPOBronze Nevada PPOBalanced-NV PPONon-HMO- HSA, HRA and HIA+-NVNevada PPO
-
HealthyBlue AdvantageHealthyBlue 2.0
-
Advantage Preferred DirectAccess Plus PPOSelect PPO
Office Locations
-
Office1321 S Rainbow Blvd Ste 220, Las Vegas, NV 89146
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Dr. Fine?
Step 1 of 3
Your review of Dr. Miles Fine, DO
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Otolaryngology-Head and Neck Surgery
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Dr. Miles Fine, DO accepts new patients on Medical News Today.
Dr. Fine accepts Anthem Blue Cross Blue Shield, Blue Cross Blue Shield, Anthem, CareFirst Blue Cross Blue Shield and Blue Cross Blue Shield of California as well as many others. See all of the insurances Dr. Fine accepts here.
Dr. Fine's office is located at 1321 S Rainbow Blvd Ste 220 Las Vegas, NV 89146. Get a map and directions to Dr. Fine's office here.
Dr. Fine does not have any reviews yet.
Dr. Fine has been practicing as an Otolaryngology-Head and Neck Surgery Specialist for 38 years.
Education & Credentials
Medical Education
-
NEW YORK INSTITUTE OF TECHNOLOGY / OLD WESTBURY
1988
Claim Your Profile
Are you Dr. Miles Fine, DO?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
The FDA has approved Moderna's new mRNA flu vaccine for adults ages 50 years and older. Moderna expects the vaccine to be available in the United States for the 2026 to 2027 flu season.
A natural compound derived from plant foods containing a certain type of polyphenol may help improve heart function in people with heart failure, a study in animals and human tissue models has found.
Moderna and Merck's neoantigen treatment, combining a personalized mRNA cancer vaccine with the immunotherapy drug pembrolizumab significantly reduced the risk of melanoma recurrence in a phase 3 trial.
